loader
Please Wait
Applying Filters...
menu
    • menu

    Approved Drug Products of Incyte Corporation listed in the FDA Orange Book. Original Data : FDA Website

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-09-09

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    Virtual Booth

    Contact Supplier

    Veranova: A CDMO that manages complexity with confidence.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-09-09

    Virtual Booth

    Contact Supplier

    Menu

    Incyte Corporation

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 3PEMIGATINIB

    02 1RETIFANLIMAB-DLWR

    03 6RUXOLITINIB PHOSPHATE

    04 1axatilimab-csfr

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    Left Arrow
    Right Arrow
    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    01

    Brand Name : NIKTIMVO

    U.S.A
    Boulder Peptide 2024
    Not Confirmed
    arrow

    Brand Name : NIKTIMVO

    U.S.A
    Boulder Peptide 2024
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD :

    TE Code :

    axatilimab-csfr

    Incyte Corporation

    Dosage Form : INJECTABLE; INTRAVENOUS

    Proprietary Name : NIKTIMVO

    Dosage Strength : 50 MG/ML

    Approval Date :

    Application Number : 761411

    RX/OTC/DISCN :

    RLD :

    TE Code :

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    02

    Brand Name : PEMAZYRE

    U.S.A
    Boulder Peptide 2024
    Not Confirmed
    arrow

    Brand Name : PEMAZYRE

    U.S.A
    Boulder Peptide 2024
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : Yes

    TE Code :

    PEMIGATINIB

    Incyte Corporation

    Dosage Form : TABLET; ORAL

    Proprietary Name : PEMAZYRE

    Dosage Strength : 4.5MG

    Approval Date : 2020-04-17

    Application Number : 213736

    RX/OTC/DISCN : RX

    RLD : Yes

    TE Code :

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    03

    Brand Name : PEMAZYRE

    U.S.A
    Boulder Peptide 2024
    Not Confirmed
    arrow

    Brand Name : PEMAZYRE

    U.S.A
    Boulder Peptide 2024
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : Yes

    TE Code :

    PEMIGATINIB

    Incyte Corporation

    Dosage Form : TABLET; ORAL

    Proprietary Name : PEMAZYRE

    Dosage Strength : 9MG

    Approval Date : 2020-04-17

    Application Number : 213736

    RX/OTC/DISCN : RX

    RLD : Yes

    TE Code :

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    04

    Brand Name : PEMAZYRE

    U.S.A
    Boulder Peptide 2024
    Not Confirmed
    arrow

    Brand Name : PEMAZYRE

    U.S.A
    Boulder Peptide 2024
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : Yes

    TE Code :

    PEMIGATINIB

    Incyte Corporation

    Dosage Form : TABLET; ORAL

    Proprietary Name : PEMAZYRE

    Dosage Strength : 13.5MG

    Approval Date : 2020-04-17

    Application Number : 213736

    RX/OTC/DISCN : RX

    RLD : Yes

    TE Code :

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    05

    Brand Name : ZYNYZ

    U.S.A
    Boulder Peptide 2024
    Not Confirmed
    arrow

    Brand Name : ZYNYZ

    U.S.A
    Boulder Peptide 2024
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD :

    TE Code :

    RETIFANLIMAB-DLWR

    Incyte Corporation

    Dosage Form : INJECTABLE; INTRAVENOUS

    Proprietary Name : ZYNYZ

    Dosage Strength : 500MG/20ML(25MG/ML)

    Approval Date :

    Application Number : 761334

    RX/OTC/DISCN :

    RLD :

    TE Code :

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    06

    Brand Name : JAKAFI

    U.S.A
    Boulder Peptide 2024
    Not Confirmed
    arrow

    Brand Name : JAKAFI

    U.S.A
    Boulder Peptide 2024
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : Yes

    TE Code :

    RUXOLITINIB PHOSPHATE

    Incyte Corporation

    Dosage Form : TABLET; ORAL

    Proprietary Name : JAKAFI

    Dosage Strength : EQ 5MG BASE

    Approval Date : 2011-11-16

    Application Number : 202192

    RX/OTC/DISCN : RX

    RLD : Yes

    TE Code :

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    07

    Brand Name : JAKAFI

    U.S.A
    Boulder Peptide 2024
    Not Confirmed
    arrow

    Brand Name : JAKAFI

    U.S.A
    Boulder Peptide 2024
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : Yes

    TE Code :

    RUXOLITINIB PHOSPHATE

    Incyte Corporation

    Dosage Form : TABLET; ORAL

    Proprietary Name : JAKAFI

    Dosage Strength : EQ 10MG BASE

    Approval Date : 2011-11-16

    Application Number : 202192

    RX/OTC/DISCN : RX

    RLD : Yes

    TE Code :

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    08

    Brand Name : JAKAFI

    U.S.A
    Boulder Peptide 2024
    Not Confirmed
    arrow

    Brand Name : JAKAFI

    U.S.A
    Boulder Peptide 2024
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : Yes

    TE Code :

    RUXOLITINIB PHOSPHATE

    Incyte Corporation

    Dosage Form : TABLET; ORAL

    Proprietary Name : JAKAFI

    Dosage Strength : EQ 15MG BASE

    Approval Date : 2011-11-16

    Application Number : 202192

    RX/OTC/DISCN : RX

    RLD : Yes

    TE Code :

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    09

    Brand Name : JAKAFI

    U.S.A
    Boulder Peptide 2024
    Not Confirmed
    arrow

    Brand Name : JAKAFI

    U.S.A
    Boulder Peptide 2024
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : Yes

    TE Code :

    RUXOLITINIB PHOSPHATE

    Incyte Corporation

    Dosage Form : TABLET; ORAL

    Proprietary Name : JAKAFI

    Dosage Strength : EQ 20MG BASE

    Approval Date : 2011-11-16

    Application Number : 202192

    RX/OTC/DISCN : RX

    RLD : Yes

    TE Code :

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    10

    Brand Name : OPZELURA

    U.S.A
    Boulder Peptide 2024
    Not Confirmed
    arrow

    Brand Name : OPZELURA

    U.S.A
    Boulder Peptide 2024
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : Yes

    TE Code :

    RUXOLITINIB PHOSPHATE

    Incyte Corporation

    Dosage Form : CREAM; TOPICAL

    Proprietary Name : OPZELURA

    Dosage Strength : EQ 1.5% BASE

    Approval Date : 2021-09-21

    Application Number : 215309

    RX/OTC/DISCN : RX

    RLD : Yes

    TE Code :

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place